Edgewise Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Edgewise Therapeutics, Inc. has filed 400 SEC EDGAR filings since 26 Sep 2019

SEC filing history

Showing 201-225 of 400 matching filings.

Per page
25
Current page
9
S-3MEF File 333-276595

S-3MEF

Filing date
19 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-264083

424B3

Filing date
19 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Dec 2023
Reporting date
26 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Dec 2023
Reporting date
26 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40236

144 filing

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40236

144 filing

Filing date
26 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date
09 Nov 2023
Reporting date
09 Nov 2023
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Aug 2023
Reporting date
17 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date
10 Aug 2023
Reporting date
10 Aug 2023
Next action
Verify source filing
SC 13D/A File 005-92424

SC 13D/A

Filing date
28 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .